Early postnatal growth and neurodevelopment in children born moderately preterm or small for gestational age at term: A systematic review.

Marion Taine, Marie-Aline Charles, Jacques Beltrand, Jean Christophe Rozé, Juliane Léger, Jérémie Botton, Barbara Heude

Journal: Paediatric and perinatal epidemiology 2018;32(3):268-280

PMID: 29691880

Abstract

BACKGROUND

Clinicians' interest in the long-term effects of early postnatal growth (EPG) is growing. There is compelling evidence linking rapid EPG with later cardiovascular risk, but its neurodevelopmental benefits still remain hypothetical in individuals born moderately preterm (MP) or small for gestational at term (SGAT).

METHODS

The objective was to perform a systematic review of the relationship between EPG before age 3 years and neurodevelopmental outcome for individuals born MP (32-36 weeks' gestational age) or SGAT. Following Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines, 3 independent investigators searched for articles published on this topic in the Web of Science, EMBASE and PubMed from database inception to July 1, 2017. A detailed quality scale was used to evaluate articles.

RESULTS

We selected 19 articles relying on 12 distinct study populations; 7 articles from 3 study populations were considered at moderate or high quality. The lack of standardisation of growth analysis methods prevented performing a meta-analysis. Overall, EPG was positively associated with neurodevelopmental outcome, especially Intelligence Quotient (IQ) when available. In this relationship, the first 6 months of life might be a critical period. Analysis of the few articles investigating the shape of the relationships revealed a non-linear association, with a plateau for IQ with higher weight gain, which suggests a possible ceiling effect.

CONCLUSIONS

A positive association was generally found between EPG and neurodevelopmental outcome for individuals born MP or SGAT. Strategies for future epidemiological studies are suggested to improve the characterisation of this relationship.

© 2018 John Wiley & Sons Ltd.

Address: Early Determinants of Children's Health and Development Team (ORCHAD), Inserm UMR1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Villejuif, France.; Paris Descartes University, Paris, France.; Department of Paediatric endocrinology, Necker Enfants Malades Hospital, Paris, France.; Inserm UMR 1016, Cochin Institute, Paris, France.; Department of Paediatric Medicine, Nantes University Hospital, Nantes, France.; Inserm CIC 1413, Clinical Investigation Center, Nantes University Hospital, Nantes, France.; Department of Paediatric Endocrinology, Robert Debré Hospital, Paris Diderot University, Paris, France.; DHU Protect, Inserm UMR 1141, Paris, France.; University Paris-Sud, University Paris-Saclay, F-92296, Châtenay-Malabry, France.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.